FDA issued Emergency Use Authorization to Yale School of Public Health for SalivaDirect method of saliva sample processing
On Aug. 15, 2020, the FDA issued an emergency use authorization (EUA) to Yale School of Public Health for its SalivaDirect COVID-19 diagnostic test, which uses a new method of processing saliva samples when testing for COVID-19 infection.
SalivaDirect does not require any special type of swab or collection device; a saliva sample can be collected in any sterile container.
Tags:
Source: U.S. Food and Drug Administration
Credit:
